Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Gasoline Fund Lp
UGA
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
US Stock MarketDetailed Quotes
Tarsus Pharmaceuticals (TARS)
- 62.480
- -2.700-4.14%
Close May 15 16:00 ET
- 61.000
- -1.480-2.37%
Post 20:01 ET
2.69BMarket Cap-56.29P/E (TTM)
65.980High61.940Low720.84KVolume65.000Open65.180Prev Close45.37MTurnover2.20%Turnover RatioLossP/E (Static)43.02MShares85.25052wk High7.70P/B2.04BFloat Cap38.51052wk Low--Dividend TTM32.72MShs Float85.250Historical High--Div Yield TTM6.20%Range %10.800Historical Low62.944Avg Price1Lot Size
Tarsus Pharmaceuticals (TARS) Key Financial Indicators
TARS Earnings per Share (EPS)
According to the latest financial report of Tarsus Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.16. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
TARS Free Cash Flow (FCF)
Interested in knowing about Tarsus Pharmaceuticals's free cash flow? The latest report shows it as -30.47M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
TARS Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Tarsus Pharmaceuticals shows that the company's current ratio is 3.74, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
TARS Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Tarsus Pharmaceuticals, the quick ratio is 3.53, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
TARS Return on Equity (ROE)
Want to learn more about the financial health of Tarsus Pharmaceuticals? The latest ROE figure is -2.01%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
TARS Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Tarsus Pharmaceuticals, the total asset return on investment (ROA) is -1.22%.
Currency: USD
Quarterly
Loading...
TARS Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Tarsus Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 94.20%.
Currency: USD
Quarterly
Loading...
TARS Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Tarsus Pharmaceuticals, the net profit margin is -4.30%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm